ArticleEuropean journal of radiology open2026
Contrast dose determined by body weight and tube potential in coronary CT angiography improves attenuation consistency and reduces contrast dose.
Article in European journal of radiology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare non-standardized and standardized dosage of contrast medium in single-heartbeat coronary CT angiography examinations in relation to tube potential, and to assess the effect of a revised contrast administration protocol standardizing dose by body weight. Materials and Methods: This single-center, retrospective, observational study included a total of 338 patients (189 men and 149 women) who had undergone high-pitch acquisition (single heartbeat) coronary CT angiography, performed with a fixed injection rate of 6.0 ml/s. Examination quality was objectively assessed by measuring the attenuation in Hounsfield Units [HU] in the ascending aorta (below optimal: <350 HU, optimal: 350-550 HU, above optimal: >550 HU) and subsequently compared to contrast dose in milligrams Iodine per kilogram of body weight, grouped by tube potential (low: 70-80 kVp, high: ≥90 kVp). Results: Comparing examinations performed prior to and after the protocol revision standardizing the dose by kilogram body weight, contrast medium dose was on average reduced by 14 % for low tube potential and 9 % for high tube potential. The number of examinations falling within optimal attenuation range increased from 13 % to 25 % for low tube potential, and 57 % to 74 % for high tube potential. However, examinations with suboptimal attenuation increased from 1 % to 8 %, typically with low body weight in conjunction with low tube potential. Conclusion: Employing a body weight adjusted contrast medium dose, while adjusting for low versus high tube potential, increases the number of examinations with attenuation falling within the clinically recommended range and reduces contrast medium dose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.